Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Aileron Therapeutics (ALRN)

Aileron Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALRN
DateTimeSourceHeadlineSymbolCompany
06/05/202421:05GlobeNewswire Inc.Aileron Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:ALRNAileron Therapeutics Inc
03/05/202421:05GlobeNewswire Inc.Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 MillionNASDAQ:ALRNAileron Therapeutics Inc
01/05/202413:45GlobeNewswire Inc.Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 MillionNASDAQ:ALRNAileron Therapeutics Inc
01/05/202413:30GlobeNewswire Inc.Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)NASDAQ:ALRNAileron Therapeutics Inc
15/04/202422:20GlobeNewswire Inc.Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ALRNAileron Therapeutics Inc
12/03/202412:00GlobeNewswire Inc.Aileron Therapeutics Announces CEO TransitionNASDAQ:ALRNAileron Therapeutics Inc
06/03/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
29/02/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
15/02/202421:05GlobeNewswire Inc.Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader EventNASDAQ:ALRNAileron Therapeutics Inc
13/02/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
06/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ALRNAileron Therapeutics Inc
05/02/202418:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALRNAileron Therapeutics Inc
01/02/202421:30GlobeNewswire Inc.Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024NASDAQ:ALRNAileron Therapeutics Inc
31/01/202421:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ALRNAileron Therapeutics Inc
29/01/202421:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALRNAileron Therapeutics Inc
29/01/202421:10Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ALRNAileron Therapeutics Inc
29/01/202413:48Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ALRNAileron Therapeutics Inc
29/01/202413:46Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ALRNAileron Therapeutics Inc
29/01/202413:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
25/01/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
19/01/202421:44Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ALRNAileron Therapeutics Inc
11/01/202421:18Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ALRNAileron Therapeutics Inc
10/01/202421:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
18/12/202322:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
21/11/202321:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
16/11/202313:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ALRNAileron Therapeutics Inc
13/11/202322:08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ALRNAileron Therapeutics Inc
03/11/202300:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
03/11/202300:50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
03/11/202300:47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ALRN